Cargando…
Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for Cancer
Overexpressed receptors, characteristic of many cancers, have been targeted by various researchers to achieve a more specific treatment for cancer. A common approach is to use the natural ligand for the overexpressed receptor as a cancer-targeting agent which can deliver a chemically or genetically...
Autores principales: | Yoon, Dennis J., Liu, Christina T., Quinlan, Devin S., Nafisi, Parsa M., Kamei, Daniel T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069328/ https://www.ncbi.nlm.nih.gov/pubmed/21350890 http://dx.doi.org/10.1007/s10439-011-0280-y |
Ejemplares similares
-
Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017) -
Ligand Valency Affects Transcytosis, Recycling and Intracellular Trafficking Mediated by the Neonatal Fc Receptor
por: Tesar, Devin B, et al.
Publicado: (2006) -
Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
por: Ritchie, Michael, et al.
Publicado: (2013) -
Formulation and Intracellular Trafficking of Lipid–Drug
Conjugate Nanoparticles Containing a Hydrophilic Antitubercular Drug
for Improved Intracellular Delivery to Human Macrophages
por: Pandit, Sayantan, et al.
Publicado: (2020) -
Regulation of ligand-independent Notch signal through intracellular trafficking
por: Hori, Kazuya, et al.
Publicado: (2012)